Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation
暂无分享,去创建一个
[1] M. Omary,et al. Keratin 8 mutations in patients with cryptogenic liver disease. , 2001, The New England journal of medicine.
[2] G. Gores,et al. Apoptosis in cancer: cause and cure , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[3] P. Krammer,et al. CD95's deadly mission in the immune system , 2000, Nature.
[4] M. Hengartner. The biochemistry of apoptosis , 2000, Nature.
[5] M. Seldin,et al. Fas-mediated apoptosis of proliferating, transiently growth-arrested, and senescent normal human fibroblasts. , 2000, Experimental cell research.
[6] P. Matarrese,et al. CD95 (APO‐1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway , 2000, The EMBO journal.
[7] R. Goldman,et al. Intermediate Filaments on the Move , 2000, The Journal of cell biology.
[8] M. Manns,et al. Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failure , 2000 .
[9] M. Peter,et al. Identification of the Cytolinker Plectin as a Major Early In Vivo Substrate for Caspase 8 during CD95- and Tumor Necrosis Factor Receptor-Mediated Apoptosis , 2000, Molecular and Cellular Biology.
[10] M. Black,et al. Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant. , 2000, Human gene therapy.
[11] S. Fulda,et al. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. , 2000, Cancer research.
[12] G. Gores,et al. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[13] S. Kanzler,et al. Apoptosis and the liver. , 2000, Seminars in cancer biology.
[14] D. Lawrence,et al. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. , 2000, Immunity.
[15] J. Blenis,et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. , 2000, Immunity.
[16] S. Strom,et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.
[17] C. Ware,et al. Keratin-Dependent, Epithelial Resistance to Tumor Necrosis Factor-Induced Apoptosis , 2000, The Journal of cell biology.
[18] K. Zatloukal,et al. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. , 2000, The American journal of pathology.
[19] N. Kaplowitz,et al. Colchicine protects mice from the lethal effect of an agonistic anti-Fas antibody. , 2000, The Journal of clinical investigation.
[20] S. Cosulich,et al. The role of protein kinase B and mitogen‐activated protein kinase in epidermal growth factor and tumor necrosis factor α–mediated rat hepatocyte survival and apoptosis , 2000, Hepatology.
[21] U. Aebi,et al. Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. , 2000, Current opinion in cell biology.
[22] A. Hara,et al. Effects of Fas-mediated liver cell apoptosis on diethylnitrosamine-induced hepatocarcinogenesis in mice , 2000, British Journal of Cancer.
[23] M. Rolfe,et al. Role for tumor necrosis factor α receptor 1 and interleukin‐1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin , 1999, Hepatology.
[24] S. Nagata,et al. Fas ligand-induced apoptosis. , 1999, Annual review of genetics.
[25] P. Krammer. CD95(APO-1/Fas)-mediated apoptosis: live and let die. , 1999, Advances in immunology.
[26] M. Omary,et al. The cytoskeleton of digestive epithelia in health and disease. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[27] E. Martínez-Salas. Internal ribosome entry site biology and its use in expression vectors. , 1999, Current opinion in biotechnology.
[28] J. Fox,et al. Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. , 1999, The American journal of pathology.
[29] S. Anderson,et al. Epidermal Growth Factor Protects Epithelial Cells against Fas-induced Apoptosis , 1999, The Journal of Biological Chemistry.
[30] J. Downward,et al. Role of Phosphoinositide 3-Kinase in Activation of Ras and Mitogen-Activated Protein Kinase by Epidermal Growth Factor , 1999, Molecular and Cellular Biology.
[31] V. Dixit,et al. Apoptosis control by death and decoy receptors. , 1999, Current opinion in cell biology.
[32] D. Tang,et al. Cycloheximide-induced T-cell Death Is Mediated by a Fas-associated Death Domain-dependent Mechanism* , 1999, The Journal of Biological Chemistry.
[33] Ingo Schmitz,et al. The Role of c-FLIP in Modulation of CD95-induced Apoptosis* , 1999, The Journal of Biological Chemistry.
[34] E. Reddy,et al. Modulation of life and death by the TNF receptor superfamily , 1998, Oncogene.
[35] Y. Iwakura,et al. Involvement of Fas/Fas ligand system‐mediated apoptosis in the development of concanavalin A‐induced hepatitis , 1998, European journal of immunology.
[36] J. Boyer,et al. Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] J P Luzio,et al. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. , 1998, Science.
[38] M. Peter,et al. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. , 1998, Current opinion in immunology.
[39] J. Tschopp,et al. Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.
[40] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[41] D. Lacey,et al. Keratinocyte growth factor protects murine hepatocytes from tumor necrosis factor–induced apoptosis in vivo and in vitro , 1998, Hepatology.
[42] L. Moldawer,et al. Disparate Roles for TNF-α and Fas Ligand in Concanavalin A-Induced Hepatitis , 1998, The Journal of Immunology.
[43] K. Zatloukal,et al. Lessons from Keratin 18 Knockout Mice: Formation of Novel Keratin Filaments, Secondary Loss of Keratin 7 and Accumulation of Liver-specific Keratin 8-Positive Aggregates , 1998, The Journal of cell biology.
[44] E. Fuchs,et al. A structural scaffolding of intermediate filaments in health and disease. , 1998, Science.
[45] Jennifer,et al. Simple epithelium keratins are required for maintenance of hepatocyte integrity. , 1997, The American journal of pathology.
[46] George Kollias,et al. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis , 1997, European journal of immunology.
[47] G. Salvesen,et al. Caspase Cleavage of Keratin 18 and Reorganization of Intermediate Filaments during Epithelial Cell Apoptosis , 1997, The Journal of cell biology.
[48] Y. Iwakura,et al. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.
[49] M. Omary,et al. Intermediate filament proteins of the liver: Emerging disease association and functions , 1997, Hepatology.
[50] A. Klippel,et al. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.
[51] C. Sarraf,et al. Reversal of phenobarbital‐induced hyperplasia and hypertrophy in the livers of lpr mice , 1997, International journal of experimental pathology.
[52] J. Fox,et al. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis , 1996, Infection and immunity.
[53] M. Benito,et al. Apoptosis induced by transforming growth factor-beta in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates. , 1996, The Journal of biological chemistry.
[54] H. Isom,et al. Apoptosis induced by tumor necrosis factor-alpha in rat hepatocyte cell lines expressing hepatitis B virus. , 1996, The American journal of pathology.
[55] A. Chinnaiyan,et al. FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.
[56] Hong-Bing Shu,et al. TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.
[57] M. Peter,et al. Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.
[58] R. Mulligan,et al. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[59] C. Thompson,et al. Apoptosis in the pathogenesis and treatment of disease , 1995, Science.
[60] R. Iozzo,et al. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. , 1994, Genes & development.
[61] S. Nagata,et al. Fas-mediated apoptosis in primary cultured mouse hepatocytes. , 1994, Experimental cell research.
[62] M. Leist,et al. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. , 1994, Journal of immunology.
[63] W. Dalton,et al. Expression of cytokeratin confers multiple drug resistance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[64] S. Goff,et al. A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.
[65] M. Kirschner,et al. Autoregulation of tubulin synthesis in hepatocytes and fibroblasts , 1985, The Journal of cell biology.
[66] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[67] B. Viollet,et al. Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice , 1996, Nature Medicine.
[68] E. Lane,et al. Intermediate filaments in disease. , 1995, Current opinion in cell biology.
[69] P. Seglen. Preparation of isolated rat liver cells. , 1976, Methods in cell biology.